Citation: Jh. Laver et al., Assessment of barriers to bone marrow donation by unrelated African-American potential donors, BIOL BLOOD, 7(1), 2001, pp. 45-48
Authors:
Laver, JH
Mahmoud, H
Pick, TE
Hutchinson, RE
Weinstein, HJ
Schwenn, M
Weitzman, S
Murphy, SB
Ochoa, S
Shuster, JJ
Citation: Jh. Laver et al., Results of a randomized phase III trial in children and adolescents with advanced stage diffuse large cell non Hodgkin's lymphoma: A Pediatric Oncology Group study, LEUK LYMPH, 42(3), 2001, pp. 399-405
Authors:
Bennett, CL
Stinson, TJ
Laver, JH
Bishop, MR
Godwin, JE
Tallman, MS
Citation: Cl. Bennett et al., Cost analyses of adjunct colony stimulating factors for acute leukemia: Can they improve clinical decision making, LEUK LYMPH, 37(1-2), 2000, pp. 65-70
Authors:
Laver, JH
Barredo, JC
Amylon, M
Schwenn, M
Kurtzberg, J
Camitta, BM
Pullen, J
Link, MP
Borowitz, M
Ravindranath, Y
Murphy, SB
Shuster, J
Citation: Jh. Laver et al., Effects of cranial radiation in children with high risk T cell acute lymphoblastic leukemia: a Pediatric Oncology Group report, LEUKEMIA, 14(3), 2000, pp. 369-373
Authors:
Bennett, CL
Stinson, TJ
Lane, D
Amylon, M
Land, VJ
Laver, JH
Citation: Cl. Bennett et al., Cost analysis of filgrastim for the prevention of neutropenia in pediatricT-cell leukemia and advanced lymphoblastic lymphoma: A case for prospective economic analysis in cooperative group trials, MED PED ONC, 34(2), 2000, pp. 92-96
Authors:
Leibovitz, E
Dagan, R
Laver, JH
Piglansky, L
Raiz, S
Abboud, MR
Fliss, DM
Leiberman, A
Barzilai, A
Citation: E. Leibovitz et al., Interleukin 8 in middle ear fluid during acute otitis media: correlation with aetiology and bacterial eradication, ARCH DIS CH, 82(2), 2000, pp. 165-168
Authors:
Barzilai, A
Leibovitz, E
Laver, JH
Piglansky, L
Raiz, S
Abboud, MR
Fliss, DM
Leiberman, A
Dagan, R
Citation: A. Barzilai et al., Dynamics of interleukin-1 production in middle ear fluid during acute otitis media treated with antibiotics, INFECTION, 27(3), 1999, pp. 173-176